Metzger Michael A bought SNDX

September 8, 2025 · Form 4 insider transaction

Metzger Michael A bought 157,307 shares of Syndax Pharmaceuticals, Inc. at $10.90 per share, a transaction worth $1.71M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
157,307
Price
$10.90
Total value
$1.71M
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 8, 2025
Filing dateSeptember 8, 2025
Shares owned after455,968
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR